Literature DB >> 12149499

Human adenovirus and human cytomegalovirus infections in preterm newborns: no association with bronchopulmonary dysplasia.

Susanna Prösch1, Uta Lienicke, Christina Priemer, Gisela Flunker, Werner F Seidel, Detlev H Krüger, Roland R Wauer.   

Abstract

Connatal infection with human adenovirus (HAdV) has been recently proposed as a cofactor for the development of bronchopulmonary dysplasia (BPD) in preterm infants [Couroucli et al. 2000 Pediatr Res 47:225-232]. In another study, BPD was associated with an increased incidence of human cytomegalovirus (HCMV) infection [Sawyer et al. 1987 Am J Dis Child 141:303-305]. During a 18-mo study period, we investigated tracheal aspirates or pharyngeal aspirates and urine samples collected during the first month of life from 66 preterm newborns with very low birth weight (< or =1.500 g) for replication-potent HAdV as well as for adenoviral and HCMV DNA by virus culture and qualitative DNA PCR. Thus, our study included not only prenatal but also peri- and postnatal infections. Thirty-seven percent (24/66) of infants developed BPD(1), as defined by persistent oxygen dependency at day 28 of life. Replication-potent HAdV and/or adenoviral DNA could be detected repeatedly in tracheal aspirates/pharyngeal aspirates and/or urine from 20% (13/66) of preterm infants. Seventeen percent (4/24) of infants in the BPD(1) group and 21% (9/42) of infants in the non-BPD group had an HAdV infection, indicating that in our study the very recently proposed association between HAdV infection of the lung and BPD could not be confirmed. For comparison, active HCMV infection was diagnosed in 18% (12/66) of infants, 3 of which developed HCMV disease. 29% (7/24) in the BPD(1) group and 12% (5/42) in the non-BPD group were positive for HCMV. Again, there was no statistically significant association between HCMV infection and BPD. In summary, our findings indicate that HAdV and HCMV infection are frequent in preterm newborns with very low birth weight; however, a causal association with the development of BPD seems unlikely.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149499     DOI: 10.1203/00006450-200208000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes.

Authors:  Sagori Mukhopadhyay; Sarah A Meyer; Sallie R Permar; Karen M Puopolo
Journal:  Am J Perinatol       Date:  2016-04-08       Impact factor: 1.862

2.  Efficient linking of birth certificate and newborn screening databases for laboratory investigation of congenital cytomegalovirus infection and preterm birth: Florida, 2008.

Authors:  John M DePasquale; Karen Freeman; Minal M Amin; Sohyun Park; Samantha Rivers; Richard Hopkins; Michael J Cannon; Bonifacio Dy; Sheila C Dollard
Journal:  Matern Child Health J       Date:  2012-02

3.  Quantitation of adenovirus genome during acute infection in normal children.

Authors:  Hiroko Shike; Chisato Shimizu; John Kanegaye; Jennifer L Foley; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2005-01       Impact factor: 2.129

4.  Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants.

Authors:  Johannes Meier; Uta Lienicke; Edda Tschirch; Detlev H Krüger; Roland R Wauer; Susanna Prösch
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Molecular evidence of Ureaplasma urealyticum and Ureaplasma parvum colonization in preterm infants during respiratory distress syndrome.

Authors:  Rosario Cultrera; Silva Seraceni; Rossella Germani; Carlo Contini
Journal:  BMC Infect Dis       Date:  2006-11-21       Impact factor: 3.090

6.  Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia.

Authors:  Matthew S Kelly; Daniel K Benjamin; Karen M Puopolo; Matthew M Laughon; Reese H Clark; Sagori Mukhopadhyay; Daniel K Benjamin; P Brian Smith; Sallie R Permar
Journal:  JAMA Pediatr       Date:  2015-12-07       Impact factor: 26.796

Review 7.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.